SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
02-Oct-12 4:33 PM View: | Par Pharmaceutical Companie... (PRX) | 28-Sep-12 | Disposition | 57,250 | $50.00 | $2,862,500.00 | (100%) 57.25K to 0 | |
24-Jul-12 6:22 PM View: | Par Pharmaceutical Companie... (PRX) | 23-Jul-12 | Payment of Exercise | 624 | $50.19 | $31,318.60 | (1%) 57.87K to 57.25K | 0% |
17-May-12 5:45 PM View: | Par Pharmaceutical Companie... (PRX) | 16-May-12 | Payment of Exercise | 903 | $40.34 | $36,427.00 | (2%) 58.78K to 57.87K | 0% |
13-Jan-12 5:12 PM View: | Par Pharmaceutical Companie... (PRX) | 11-Jan-12 | Payment of Exercise | 482 | $35.65 | $17,183.30 | (< 1%) 59.26K to 58.78K | (< 1%) |
11-Jan-12 5:41 PM View: | Par Pharmaceutical Companie... (PRX) | 09-Jan-12 | Payment of Exercise | 481 | $35.09 | $16,878.30 | (< 1%) 59.74K to 59.26K | (3%) |
09-Jan-12 5:56 PM View: | Par Pharmaceutical Companie... (PRX) | 06-Jan-12 | Payment of Exercise | 687 | $34.01 | $23,364.90 | (1%) 60.43K to 59.74K | 0% |
09-Jan-12 5:56 PM View: | Par Pharmaceutical Companie... (PRX) | 05-Jan-12 | Grant | 11,447 | -- | -- | 23% 48.98K to 60.43K | |
06-Jan-12 4:55 PM View: | Par Pharmaceutical Companie... (PRX) | 04-Jan-12 | Payment of Exercise | 340 | $32.17 | $10,937.80 | (< 1%) 50.32K to 49.98K | (2%) |
07-Sep-11 2:43 PM View: | Par Pharmaceutical Companie... (PRX) | 06-Sep-11 | Market Purchase | 2,000 | $27.50 | $55,000.00 | 4% 47.32K to 49.32K | (2%) |
25-Jul-11 3:09 PM View: | Par Pharmaceutical Companie... (PRX) | 21-Jul-11 | Payment of Exercise | 780 | $34.61 | $26,995.80 | (2%) 48.1K to 47.32K | < 1% |
18-May-11 5:33 PM View: | Par Pharmaceutical Companie... (PRX) | 16-May-11 | Grant | 10,794 | -- | -- | 29% 37.31K to 48.1K | |
24-Mar-11 5:39 PM View: | Par Pharmaceutical Companie... (PRX) | 22-Mar-11 | Payment of Exercise | 787 | $29.00 | $22,823.00 | (2%) 38.09K to 37.31K | < 1% |
13-Jan-11 6:32 PM View: | Par Pharmaceutical Companie... (PRX) | 11-Jan-11 | Grant | 5,039 | -- | -- | 14% 37.13K to 42.17K | |
13-Jan-11 6:32 PM View: | Par Pharmaceutical Companie... (PRX) | 11-Jan-11 | Payment of Exercise | 4,095 | $35.98 | $147,338.00 | (10%) 42.17K to 38.07K | < 1% |
12-Jan-11 4:17 PM View: | Par Pharmaceutical Companie... (PRX) | 10-Jan-11 | Payment of Exercise | 481 | $36.00 | $17,316.00 | (1%) 37.61K to 37.13K | < 1% |
10-Jan-11 6:08 PM View: | Par Pharmaceutical Companie... (PRX) | 06-Jan-11 | Grant | 8,188 | -- | -- | 28% 29.42K to 37.61K | |
06-Jan-11 5:40 PM View: | Par Pharmaceutical Companie... (PRX) | 04-Jan-11 | Payment of Exercise | 340 | $39.79 | $13,528.60 | (1%) 29.76K to 29.42K | 4% |
22-Dec-10 2:15 PM View: | Par Pharmaceutical Companie... (PRX) | 20-Dec-10 | Payment of Exercise | 837 | $38.26 | $32,023.60 | (3%) 30.6K to 29.76K | (< 1%) |
23-Jul-10 9:36 AM View: | Par Pharmaceutical Companie... (PRX) | 21-Jul-10 | Grant | 7,179 | -- | -- | 31% 23.42K to 30.6K |